PMAM
IQMDU

Picton Mahoney Asset Management’s Intelligent Medicine Acquisition Corp. Unit IQMDU Stock Holding History

Picton Mahoney Asset Management’s Portfolio IQMDU Stock Details IQMDU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200,000
Closed -$2.04M – 1132
2021
Q4 		$2.04M Buy
+200,000
New +$2.03M 0.05% 344

Other funds holding IQMDU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.97% 1-Year Est. Return
DCM
Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Picton Mahoney Asset Management's IQMDU Position: Q1 2022 in Review

Picton Mahoney Asset Management sold out of Intelligent Medicine Acquisition Corp. Unit (IQMDU) in Q1 2022, closing a stake of 200,000 shares — an estimated $2.04M sold.

Picton Mahoney Asset Management first reported a position in IQMDU in Q4 2021 and held it in 1 quarter. The position peaked at $2.04M in Q4 2021. 26 funds tracked by Wall St. Rank hold IQMDU as of Q1 2022.

  • Picton Mahoney Asset Management reported no remaining Intelligent Medicine Acquisition Corp. Unit position as of Q1 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 200,000 Intelligent Medicine Acquisition Corp. Unit shares in Q1 2022, an estimated $2.04M.
  • Picton Mahoney Asset Management first reported a position in Intelligent Medicine Acquisition Corp. Unit in Q4 2021 and held it in 1 quarter.
  • Picton Mahoney Asset Management's Intelligent Medicine Acquisition Corp. Unit position peaked at $2.04M in Q4 2021.
  • 26 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Unit as of Q1 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2022, filed 11 May 2022.